Vetsina Animal Diagnostics appoints Simon Wheeler as its first CEO

Published Wednesday, 8th July 2020

Vetsina Animal Diagnostics "the new company formed by Roslin Technologies and DESTINA Genomics" has announced the appointment of Dr. Simon Wheeler as its first Chief Executive Officer (CEO).

Dr. Wheeler is a veterinarian and strategic leader with over 20 years' experience of the global animal health industry. He has previously held strategic, technical, marketing and innovation roles in various companies, including Pharmacia and Novartis.

He also reached senior positions in clinical veterinary academia in the UK and US, lecturing at international meetings and conducting research, as well as publishing three books and over 125 articles and chapters, and mentoring trainees. He has received a number of awards for teaching and contributions to veterinary surgery.

"With his range of experience and skills, Simon is a great fit with the position of CEO at this exciting new company", said Hugh Ilyine, CEO of DESTINA and Executive Director of Vetsina.  "We know Vetsina's development and growth is in good hands."

Recently, Dr. Wheeler has held several consultancies, including Chief Operating Officer of Roslin Technologies, an Edinburgh-based biotech start up, and he was commercial consultant to Advanced Anaesthesia Specialists. He has supported various biotech companies as well as holding several board positions.

ends

Editor's notes:

About Vetsina Animal Diagnostics

Vetsina Animal Diagnostics has been established to maximise the impact of a revolutionary chemical-based system for detecting nucleic acids and single nucleotide polymorphisms, for the development of simple, fast, accurate & cost-effective products for PCR-free detection of microRNAs in human medicine, by applying it to animal health.

Vetsina will also research the animal diagnostics arena to focus on targets based on market need, technical feasibility and the development of a balanced portfolio.

It was founded by Roslin Technologies and DESTINA Genomics.

About Roslin Technologies

Roslin Technologies is a technology commercialisation company based at Easter Bush Campus, at the centre of the largest concentration of animal science expertise in Europe. The company was created to develop commercial opportunities from the research, know-how, capabilities and intellectual property of The Roslin Institute and The Royal (Dick) School of Veterinary Studies.

Roslin Technologies develop and supply products and services to industry, as well as providing opportunities for investors looking to capitalise on the growing demand for food and agricultural products. For additional information, visit www.roslintech.com.

About DESTINA Genomics

DESTINA Genomics Ltd is a biotech company founded in Edinburgh in 2011 by Hugh Ilyine, Juan J. Diaz-Mochon and Mark Bradley. In July 2012, a Spanish subsidiary DESTINA Genomica S.L. was created with the goal to accelerate a long-term growth plan. The company is focused on the application and validation of its patented state-of-the-art technologies. For additional information, visit https://DESTINAgenomics.com/

For more information contact Mike Keeler (mike.keeler@garnettkeeler.com) or Alistair Moses (alistair.moses@garnettkeeler.com) at Garnett Keeler PR on +44 (0)20 8647 4467.

Cookie policy

We use necessary cookies to allow our site to function correctly. You can disable these via your browser settings but this site may not function correctly if you do so. We also use optional cookies to collect anonymised visitor statistics to help us identify issues and improve our web site. View our privacy policy here

Cookies